Development of Carbamazepine Nanostructured Lipid Carrier Loaded Thermosensitive Gel for Intranasal Delivery

Sanjeevani Shekhar Deshkar ¹ * , Monali Shivaji Jadhav ¹, Satish Vasudeo Shirolkar ¹

Cited by CrossRef: 32

1- Susa F, Arpicco S, Pirri C, Limongi T. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery. Pharmaceutics. 2024;16(7):849 [Crossref]

2- Lin C, Li Y, Chen Y, Kuo C, Tu T, Liu Y, Tsai J, Shyong Y. Amphiphilic NLC-Gel formulation loaded with Sebacoyl dinalbuphine ester and Nalbuphine for localized postoperative pain management. International Journal of Pharmaceutics. 2024;659:124295 [Crossref]

3- Abou-Elnour F, El-Habashy S, Essawy M, Abdallah O. Codelivery of ivermectin and methyl dihydrojasmonate in nanostructured lipid carrier for synergistic antileukemia therapy. International Journal of Pharmaceutics. 2024;656:124086 [Crossref]

4- Bonaccorso A, Gigliobianco M, Lombardo R, Pellitteri R, Di Martino P, Mancuso A, Musumeci T. Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development. Pharmaceutical Development and Technology. 2023;28(2):248 [Crossref]

5- Mahor A, Singh P, Gupta R, Bhardwaj P, Rathore P, Kishore A, Goyal R, Sharma N, Verma J, Rosenholm J, Bansal K, Jan N. Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route. Journal of Nanotechnology. 2023;2023:1 [Crossref]

6- Pina Costa C, Nižić Nodilo L, Silva R, Martins E, Zadravec D, Kalogjera L, Nuno Moreira J, Manuel Sousa Lobo J, Hafner A, Catarina Silva A. In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model. International Journal of Pharmaceutics. 2023;644:123345 [Crossref]

7- Anjali P, Jawahar N, Praharsh Kumar M, Jubie S, Selvamuthukumar S. Nanocarriers in the treatment of epilepsy: Challenges and opportunities. Journal of Drug Delivery Science and Technology. 2024;97:105788 [Crossref]

8- Shete M, Deshpande A, Shende P. Nanostructured lipid carrier-loaded metformin hydrochloride: Design, optimization, characterization, assessment of cytotoxicity and ROS evaluation. Chemistry and Physics of Lipids. 2023;250:105256 [Crossref]

9- da Silva M, de Godoi K, Gigante M, Pavie Cardoso L, Paula Badan Ribeiro A. Developed and characterization of nanostructured lipid carriers containing food-grade interesterified lipid phase for food application. Food Research International. 2022;155:111119 [Crossref]

10- Mfoafo K, Omidi Y, Omidian H. Thermoresponsive mucoadhesive hybrid gels in advanced drug delivery systems. International Journal of Pharmaceutics. 2023;636:122799 [Crossref]

11- Constantinou A, Georgiou T. Pre‐clinical and clinical applications of thermoreversible hydrogels in biomedical engineering: a review. Polymer International. 2021;70(10):1433 [Crossref]

12- Nguyen T, Duong V. Solid Lipid Nanoparticles. Encyclopedia. 2022;2(2):952 [Crossref]

13- Jawad M, Shafique U, Din F, Butt A, Khan S, Khan G, Alamri A, Lahiq A, Alsharif S, Almerai K. Nose to brain delivery of escitalopram-loaded nano-structured lipid carriers thermosensitive gel: Formulation, physiochemical, pharmacokinetic and pharmacodynamics evaluation. Journal of Drug Delivery Science and Technology. 2024;97:105800 [Crossref]

14- Salave S, Rana D, Pardhe R, Bule P, Benival D. Unravelling Micro and Nano Vesicular System in Intranasal Drug Delivery for Epilepsy. PNT. 2022;10(3):182 [Crossref]

15- Kumar V, Nair S. Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances. BIOT. 2024;18(1):2 [Crossref]

16- Mirza R, Shah K, Khan A, Fawad M, Rehman A, Ahmed N, Nawaz A, Shah S, Alasmari A, Alharbi M, Alasmari F, Hafeez Z, Haq S. Statistical design and optimization of nano-transfersomes based chitosan gel for transdermal delivery of cefepime. Drug Development and Industrial Pharmacy. 2024;50(6):511 [Crossref]

17- Chiprikar P, Mastiholimath V, Biradar P, Shirkoli N. Quality by Design Approach for the Development of Cariprazine Hydrochloride Loaded Lipid-Based Formulation for Brain Delivery via Intranasal Route. CDM. 2024;25(7):523 [Crossref]

18- Ikram M, Rasheed S. Genetics of Dravet Syndrome and its Targeted Therapy by Nanomedicine: A Roadmap for Future Treatment of Drug Resistant Seizures. CMP. 2023;16(4):475 [Crossref]

19- Elmanawy M, Boraie N, Bakr B, Makled S. Augmented ocular uptake and anti-inflammatory efficacy of decorated Genistein-loaded NLCs incorporated in in situ gel. International Journal of Pharmaceutics. 2024;662:124508 [Crossref]

20- Tawfeek H, Mekkawy A, Abdelatif A, Aldosari B, Mohammed-Saeid W, Elnaggar M. Intranasal delivery of sulpiride nanostructured lipid carrier to central nervous system; in vitro characterization and in vivo study. Pharmaceutical Development and Technology. 2024;29(8):841 [Crossref]

21- Gattani V, Dawre S. Development of favipiravir loaded PLGA nanoparticles entrapped in in-situ gel for treatment of Covid-19 via nasal route. Journal of Drug Delivery Science and Technology. 2023;79:104082 [Crossref]

22- Wang M, Ma X, Zong S, Su Y, Su R, Zhang H, Liu Y, Wang C, Li Y. The prescription design and key properties of nasal gel for CNS drug delivery: A review. European Journal of Pharmaceutical Sciences. 2024;192:106623 [Crossref]

23- Correia A, Moreira J, Sousa Lobo J, Silva A. Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery. Expert Opinion on Drug Delivery. 2023;20(12):1731 [Crossref]

24- Koo J, Lim C, Oh K. Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations. IJN. 2024;Volume 19:1767 [Crossref]

25- Jannapu Reddy S, Mutalik S, Viswanatha G, Kumar G, John J, Chamallamudi M, Das A, Das S, Nandakumar K. Nose-to-brain Drug Delivery System: An Emerging Approach to Chemotherapy-induced Cognitive Impairment. PNT. 2025;13(1):212 [Crossref]

26- Fan R, Sun W, Zhang T, Wang R, Tian Y, Zhang H, Li J, Zheng A, Song S. Paclitaxel-nanocrystals-loaded network thermosensitive hydrogel for localised postsurgical recurrent of breast cancer after surgical resection. Biomedicine & Pharmacotherapy. 2022;150:113017 [Crossref]

27- Kumari S, Dandamudi M, Rani S, Behaeghel E, Behl G, Kent D, O’Reilly N, O’Donovan O, McLoughlin P, Fitzhenry L. Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease. Pharmaceutics. 2021;13(6):905 [Crossref]

28- E.O. B. APPLICATION OF IN VITRO MODELING FOR PHARMACEUTICAL DEVELOPMENT OF IN SITU SYSTEMS. Mediko-farmacevtičeskij žurnal "Pulʹs". 2022;:137 [Crossref]

29- Kisku A, Nishad A, Agrawal S, Paliwal R, Datusalia A, Gupta G, Singh S, Dua K, Sulakhiya K. Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders. Front Med. 2024;11 [Crossref]

30- Nguyen T, Maeng H. Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery. Pharmaceutics. 2022;14(3):572 [Crossref]

31- Qizilbash F, Ashhar M, Zafar A, Qamar Z, Qamar A, Ali J, Baboota S, Ghoneim M, Alshehri S, Ali A. Thymoquinone-Enriched Naringenin-Loaded Nanostructured Lipid Carrier for Brain Delivery via Nasal Route: In Vitro Prospect and In Vivo Therapeutic Efficacy for the Treatment of Depression. Pharmaceutics. 2022;14(3):656 [Crossref]

32- Dawre S, Waghela S, Saraogi G. Statistically designed vitamin D3 Encapsulated PLGA microspheres dispersed in thermoresponsive in-situ gel for nasal delivery. Journal of Drug Delivery Science and Technology. 2022;75:103688 [Crossref]